Extending Contingency Management's Benefits With Progressively Increasing Variable Interval Prize Reinforcement
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Contingency Management (CM) is highly effective in promoting recovery from substance use disorders, but benefits tend to attenuate over time when CM is discontinued. Identifying modifications of CM delivery that can extend its benefits is an important goal. The goal of this study is to evaluate the use of reinforcements to increase physical activity, specifically walking. The study provides a standard CM intervention to promote walking for three weeks. After three weeks, a progressively increasing variable interval schedule of reinforcement will be evaluated for increasing the durability of effects of the initial CM intervention. We hypothesize that Variable Interval Prize Contingency Management will result in greater adherence to a walking goal of 10,000 steps per day at Week 15 and Week 24 compared to the Control Condition.
| Condition | Intervention | Phase |
|---|---|---|
|
Exercise Addictive Behaviors |
Behavioral: VIP CM |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Extending Contingency Management's Benefits With Progressively Increasing Variable Interval Prize Reinforcement |
- number of steps walked in seven days prior to follow up assessment, as verified by the pedometer [ Time Frame: week 15 ] [ Designated as safety issue: No ]
- number of steps walked in seven days prior to follow up assessment, as verified by the pedometer [ Time Frame: week 24 ] [ Designated as safety issue: No ]
| Enrollment: | 61 |
| Study Start Date: | May 2010 |
| Study Completion Date: | March 2012 |
| Primary Completion Date: | March 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: (A) Non-contingent control
Participants assigned to the control condition will be told to wear the pedometer daily and select a twice-weekly meeting schedule with research staff for 12 weeks (study weeks 4-15). On days randomly selected as meeting days, participants will be asked to bring in their pedometers. Participants who attend their scheduled meetings will receive a $5 gift card just for attending and bringing the pedometer, so long as it has registered steps walked in at least the past 4 days. They will be congratulated if they walked 10,000 steps or more on the prior 4 days, and encouraged to walk 10,000 steps or more per day on subsequent days.
|
|
|
Experimental: VIP CM
Participants assigned to Increasing Variable Interval Prize (VIP) Reinforcement group will be scheduled for the same study visits as those in the Control group, but will also earn chances to win prizes if they have walked more than 10,000 steps in the past 4 days.
|
Behavioral: VIP CM
Participants will receive progressively increasing CM for walking 10,000 steps per day over 4 days prior to visit as verified by the pedometer.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- age > 18 years
- currently not physically active
- Physically able and willing to walk 10,000 steps per day
Exclusion Criteria:
- psychiatric or physical illness that could interfere with participation
Contacts and Locations| United States, Connecticut | |
| UConn Heatlh Center | |
| Farmington, Connecticut, United States, 06030-3944 | |
| Principal Investigator: | Nancy M Petry, Ph.D. | University of Connecticut Health Center |
More Information
No publications provided
| Responsible Party: | University of Connecticut Health Center |
| ClinicalTrials.gov Identifier: | NCT01184040 History of Changes |
| Other Study ID Numbers: | 10-249-1, 1P30DA023918-01A1 |
| Study First Received: | August 10, 2010 |
| Last Updated: | June 14, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Behavior, Addictive Compulsive Behavior Impulsive Behavior |
ClinicalTrials.gov processed this record on May 22, 2013